Life sciences news
-
ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic
Friday December 18th 2020
Read more
-
Imec presents smallest finFET-based biosensor for high-sensitivity molecule detection
Friday December 18th 2020
Read more
-
Gilead and Galapagos announce New Commercialization and Development Agreement for Jyseleca® (filgotinib)
Wednesday December 16th 2020
Read more
-
Mithra announces positive DSMB safety review and continuation of its Phase III Clinical Program Donesta® in menopause
Wednesday December 16th 2020
Read more
-
OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform
Tuesday December 8th 2020
Read more
-
Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
Thursday December 3rd 2020
Read more
-
reMYND commences first-in-human trial of ReS19-T Alzheimer’s program
Thursday December 3rd 2020
Read more
-
eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities
Wednesday December 2nd 2020
Read more
-
Become a flanders.bio member
Your news here?
-
AbolerIS Pharma signed with Ouest Valorisation an exclusive world-wide license to develop new first-in-class anti-CD45RC monoclonal antibodies
Wednesday December 2nd 2020
Read more
-
atbtherapeutics initiates agreement with iBio CDMO to manufacture game-changer atbodies to better treat cancer
Tuesday December 1st 2020
Read more
-
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
Tuesday December 1st 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
